Jinling Hospital, China

This study tested whether two existing drugs, finerenone and empagliflozin, could help slow the decline of kidney function in patients at high risk after surgery to remove a kidney for cancer. Researchers compared patients taking one drug, both drugs, or no drug for one year to s…

This study tested whether giving two drugs—an immunotherapy (toripalimab) and a targeted therapy (lenvatinib)—before and sometimes after kidney removal surgery could help shrink tumors and improve outcomes for people with kidney cancer. It aimed to see how much the treatment redu…